Chenjing Xia

936 total citations
9 papers, 538 citations indexed

About

Chenjing Xia is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Chenjing Xia has authored 9 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Chenjing Xia's work include MicroRNA in disease regulation (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and RNA Interference and Gene Delivery (2 papers). Chenjing Xia is often cited by papers focused on MicroRNA in disease regulation (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and RNA Interference and Gene Delivery (2 papers). Chenjing Xia collaborates with scholars based in China, United States and Germany. Chenjing Xia's co-authors include T. Ahmad, Ronit Simantov, Tim Eisen, Maggie James, Peter J. O’Dwyer, Richard Marais, Melanie Poulin-Costello, Stan B. Kaye, Brian Schwartz and Lynn M. Schuchter and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Sensors and Actuators B Chemical.

In The Last Decade

Chenjing Xia

5 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenjing Xia China 4 439 308 74 70 68 9 538
T. Ahmad United Kingdom 7 566 1.3× 388 1.3× 78 1.1× 82 1.2× 77 1.1× 12 677
I. Gibbens United Kingdom 6 489 1.1× 381 1.2× 73 1.0× 76 1.1× 76 1.1× 9 645
Kelly E. Fisher United States 4 434 1.0× 288 0.9× 91 1.2× 87 1.2× 51 0.8× 6 599
Maggie James United States 8 568 1.3× 412 1.3× 80 1.1× 78 1.1× 76 1.1× 25 721
Karin Kemsley United Kingdom 4 363 0.8× 297 1.0× 52 0.7× 56 0.8× 31 0.5× 4 450
Zoi Karoulia United States 6 560 1.3× 238 0.8× 130 1.8× 115 1.6× 57 0.8× 9 664
Katie Kane United Kingdom 6 363 0.8× 256 0.8× 77 1.0× 50 0.7× 33 0.5× 9 531
Arthur Groy United States 6 497 1.1× 279 0.9× 109 1.5× 81 1.2× 64 0.9× 7 696
Mary Ellen Simcox United States 8 458 1.0× 351 1.1× 111 1.5× 96 1.4× 95 1.4× 12 643
Marian M. Deuker United States 6 580 1.3× 274 0.9× 118 1.6× 117 1.7× 54 0.8× 6 742

Countries citing papers authored by Chenjing Xia

Since Specialization
Citations

This map shows the geographic impact of Chenjing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenjing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenjing Xia more than expected).

Fields of papers citing papers by Chenjing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenjing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenjing Xia. The network helps show where Chenjing Xia may publish in the future.

Co-authorship network of co-authors of Chenjing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Chenjing Xia. A scholar is included among the top collaborators of Chenjing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenjing Xia. Chenjing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhao, Guodong, et al.. (2025). Serum direct SMOS-qPCR: a fast approach for miRNAs detection. Analytical Methods. 17(10). 2335–2341.
2.
Zhao, Guodong, et al.. (2025). A novel high-fidelity DNA polymerase-driven or Taq DNA polymerase-driven one-pot miRNA multiplex RT-qPCR method mediated by RT-HOS. Sensors and Actuators B Chemical. 445. 138559–138559.
3.
Zhao, Jie, et al.. (2025). The role of probiotic supplementation in reducing Helicobacter pylori recurrence after classic quadruple therapy. Frontiers in Pharmacology. 16. 1621090–1621090.
4.
Zhao, Guodong, et al.. (2025). Specific distinguishing between miRNA and pre-miRNA by blocker displacement SMOS-qPCR. Talanta. 296. 128406–128406.
5.
Li, Hui, Qianqian Wu, Jie Wang, et al.. (2023). A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers. Neoplasia. 46. 100941–100941. 8 indexed citations
6.
Alberts, Steven R., Carol E. Peña, Isabelle Genvresse, et al.. (2018). Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. British Journal of Cancer. 118(4). 462–470. 34 indexed citations
7.
Schultheis, Beate, et al.. (2011). Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 69(2). 333–339. 10 indexed citations
8.
Lettieri, John, et al.. (2009). Bioavailability of sorafenib tablets administered as a liquid suspension. Journal of Clinical Oncology. 27(15_suppl). e14549–e14549. 3 indexed citations
9.
Eisen, Tim, T. Ahmad, Keith T. Flaherty, et al.. (2006). Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. British Journal of Cancer. 95(5). 581–586. 483 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026